IFG Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,471
| Closed | -$225K | – | 678 |
|
2024
Q4 | $225K | Buy |
+1,471
| New | +$225K | 0.01% | 613 |
|
2024
Q3 | – | Sell |
-1,510
| Closed | -$350K | – | 406 |
|
2024
Q2 | $350K | Buy |
+1,510
| New | +$350K | 0.02% | 473 |
|
2024
Q1 | – | Sell |
-1,779
| Closed | -$460K | – | 385 |
|
2023
Q4 | $460K | Buy |
1,779
+93
| +6% | +$24.1K | 0.03% | 377 |
|
2023
Q3 | $433K | Buy |
+1,686
| New | +$433K | 0.04% | 372 |
|
2023
Q2 | – | Sell |
-1,686
| Closed | -$469K | – | 335 |
|
2023
Q1 | $469K | Sell |
1,686
-38
| -2% | -$10.6K | 0.04% | 331 |
|
2022
Q4 | $477K | Hold |
1,724
| – | – | 0.05% | 320 |
|
2022
Q3 | $460K | Buy |
+1,724
| New | +$460K | 0.04% | 329 |
|
2022
Q1 | – | Sell |
-1,084
| Closed | -$260K | – | 492 |
|
2021
Q4 | $260K | Hold |
1,084
| – | – | 0.03% | 425 |
|
2021
Q3 | $306K | Hold |
1,084
| – | – | 0.03% | 395 |
|
2021
Q2 | $375K | Sell |
1,084
-48
| -4% | -$16.6K | 0.04% | 349 |
|
2021
Q1 | $316K | Sell |
1,132
-37
| -3% | -$10.3K | 0.04% | 384 |
|
2020
Q4 | $286K | Sell |
1,169
-123
| -10% | -$30.1K | 0.04% | 359 |
|
2020
Q3 | $366K | Buy |
1,292
+300
| +30% | +$85K | 0.06% | 285 |
|
2020
Q2 | $265K | Sell |
992
-17
| -2% | -$4.54K | 0.05% | 327 |
|
2020
Q1 | $319K | Buy |
1,009
+44
| +5% | +$13.9K | 0.07% | 255 |
|
2019
Q4 | $286K | Sell |
965
-72
| -7% | -$21.3K | 0.05% | 322 |
|
2019
Q3 | $241K | Sell |
1,037
-1,816
| -64% | -$422K | 0.05% | 343 |
|
2019
Q2 | $667K | Sell |
2,853
-56
| -2% | -$13.1K | 0.12% | 172 |
|
2019
Q1 | $687K | Sell |
2,909
-327
| -10% | -$77.2K | 0.13% | 153 |
|
2018
Q4 | $973K | Buy |
3,236
+131
| +4% | +$39.4K | 0.23% | 104 |
|
2018
Q3 | $1.1M | Buy |
3,105
+57
| +2% | +$20.1K | 0.21% | 112 |
|
2018
Q2 | $884K | Buy |
3,048
+70
| +2% | +$20.3K | 0.18% | 124 |
|
2018
Q1 | $815K | Sell |
2,978
-157
| -5% | -$43K | 0.18% | 125 |
|
2017
Q4 | $998K | Buy |
+3,135
| New | +$998K | 0.22% | 107 |
|